Brain-Derived Neurotrophic Factor Serum Levels in Alcohol-Dependent Subjects 6 Months After Alcohol Withdrawal

被引:60
|
作者
Costa, Marie-Agnes [1 ,2 ]
Girard, Murielle [1 ]
Dalmay, Francois [3 ]
Malauzat, Dominique [1 ]
机构
[1] Ctr Hosp Esquirol, Dept Rech & Dev, F-87025 Limoges, France
[2] Ctr Hosp Esquirol, Lab Anal Biol, F-87025 Limoges, France
[3] CHU Limoges, Unite Fonct Rech Clin & Biostat, Limoges, France
关键词
BDNF; Alcohol Dependence; Withdrawal; Neuronal Plasticity; NERVE GROWTH-FACTOR; FACTOR BDNF; HOMEOSTATIC PATHWAY; HUMAN PLATELETS; USE DISORDERS; DEPRESSION; EXPRESSION; CELLS; RECEPTORS; RELAPSE;
D O I
10.1111/j.1530-0277.2011.01548.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Diagnosing alcohol dependence is based on clinical signs and on the measured levels of biological markers of alcohol consumption. However, these markers are neither sufficiently sensitive and nor specific enough to definitively determine alcohol dependence. The neuro-adaptive changes associated with alcohol dependence involve markers such as brain-derived neurotrophic factor (BDNF), which regulate neuronal plasticity. Serum levels of BDNF have been reported to decrease during alcohol dependence and may be restored to normal soon after alcohol is withdrawn. However, the long-term relationship between serum BDNF levels and abstinence status is unknown. Methods: We investigated serum BDNF levels in 101 abstinent and relapsing alcohol-dependent subjects at the moment of hospitalization for alcohol withdrawal (M0) and 6 months later (M6) and compared them to the serum BDNF levels of 41 nondependent subjects. The BDNF levels of the alcohol-dependent subjects were compared to their serum gamma glutamyl transferase (GGT) levels, mean corpuscular volume (MCV) values, and their score on the Beck Depression Inventory (BDI) questionnaire. Results: Forty-four percent of the alcohol-dependent participants remained abstinent during the 6 months following alcohol detoxification. Serum BDNF levels of the abstinent group at M6 were significantly higher than those of the original group of alcohol-dependent subjects at M0 (p = 0.034). Only the abstinent group had higher BDNF levels than the control group (p < 0.001). Serum BDNF levels increased to a greater extent in the abstinent group than in the nonabstinent group (p = 0.016). No correlations were found between serum BDNF levels and GGT level, MCV value, or BDI score. Conclusions: Our data confirm that serum BDNF levels do not correlate with either chronic alcohol consumption or peripheral toxicity but may be linked to neuronal aspects of alcohol consumption and dependence. The increased serum levels of BDNF may reflect the concomitant activation of BDNF synthesis that accompanies the neuronal remodeling triggered by alcohol withdrawal and suggests that BDNF synthesis may have a role in the long-term maintenance of abstinence. Monitoring the serum BDNF levels of alcoholics undergoing treatment could help to characterize alcohol dependence profiles and predict relapse.
引用
收藏
页码:1966 / 1973
页数:8
相关论文
共 50 条
  • [1] Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal
    Huang, Ming-Chyi
    Chen, Chun-Hsin
    Chen, Chia-Hui
    Liu, Shing-Cheng
    Ho, Chia-Jen
    Shen, Winston W.
    Leu, Sy-Jye
    ALCOHOL AND ALCOHOLISM, 2008, 43 (03): : 241 - 245
  • [2] Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen
    Geisel, Olga
    Hellweg, Rainer
    Mueller, Christian A.
    PSYCHIATRY RESEARCH, 2016, 240 : 177 - 180
  • [3] Genetic determinants of serum brain-derived neurotrophic factor (BDNF) after alcohol withdrawal
    Danil Peregud
    Alexey Korolkov
    Valeria Baronets
    Kirill Kozlov
    Anna Lobacheva
    Maxim Arkus
    Sakeena Bairamova
    Maria Solovieva
    Olga Pavlova
    Konstantin Pavlov
    Natalia Terebilina
    Discover Medicine, 1 (1):
  • [4] A review of peripheral brain-derived neurotrophic factor levels in alcohol-dependent patients: Current understanding
    Kethawath, Shanti Mohan
    Jain, Raka
    Dhawan, Anju
    Sarkar, Siddharth
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 (01) : 15 - 20
  • [5] Increase in serum brain-derived neurotrophic factor levels during early withdrawal in severe alcohol users
    Valerio, Andrei Garziera
    Ornell, Felipe
    Roglio, Vinicius Serafini
    Scherer, Juliana Nichterwitz
    Schuch, Jaqueline Bohrer
    Bristot, Giovana
    Pechansky, Flavio
    Kapczinski, Flavio
    Kessler, Felix Henrique Paim
    von Diemen, Lisia
    TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, 2022, 44
  • [6] Increase in serum brain-derived neurotrophic factor levels during early withdrawal in severe alcohol users
    Valerio, Andrei Garziera
    Ornell, Felipe
    Roglio, Vinicius Serafini
    Scherer, Juliana Nichterwitz
    Schuch, Jaqueline Bohrer
    Bristot, Giovana
    Pechansky, Flavio
    Kapczinski, Flavio
    Paim Kessler, Felix Henrique
    von Diemen, Lisia
    TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY, 2022, 44 : e20210254
  • [7] NEUROPEPTIDE Y (NPY) AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) RESPONSIVITY AFTER ACUTE STRESS IN ALCOHOL-DEPENDENT AND CONTROL SUBJECTS
    Meng, Y.
    Rao, U.
    Xiao, H.
    North, C. S.
    Adinoff, B.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 15A - 15A
  • [8] Alterations of brain-derived neurotrophic factor serum levels in alcohol dependence patients
    Zanardini, R.
    Fontana, A.
    Gennarelli, M.
    Bocchio-Chiavetto, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S575 - S576
  • [9] Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence
    Zanardini, Roberta
    Fontana, Aldo
    Pagano, Raffaella
    Mazzaro, Emilio
    Bergamasco, Francesco
    Romagnosi, Giuliano
    Gennarelli, Massimo
    Bocchio-Chiavetto, Luisella
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (08) : 1529 - 1533
  • [10] Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence
    Umene-Nakano, Wakako
    Yoshimura, Reiji
    Ikenouchi-Sugita, Atsuko
    Hori, Hikaru
    Hayashi, Kenji
    Ueda, Nobuhisa
    Nakamura, Jun
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (05) : 409 - 413